GO TO NEWSROOMeast
iTeos Logo 2022.png
iTeos meldet Finanzergebnisse für das erste Quartal 2024 und gibt aktuelle Geschäftsinformationen bekannt
May 11, 2024 13:31 ET | iTeos Therapeutics Inc.
- Belrestotug + Dostarlimab übertraf die vordefinierten Wirksamkeitskriterien für klinisch relevante Aktivität, die in einer Zwischenbewertung der Phase 2 von GALAXIES Lung-201 beobachtet wurde -...
July 30, 2021 - ROSEN LOGO.jpg
ROSEN, A LEADING NATIONAL FIRM, Encourages QuidelOrtho Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – QDEL
May 11, 2024 10:37 ET | The Rosen Law Firm PA
NEW YORK, May 11, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of QuidelOrtho Corporation (NASDAQ: QDEL) between February 18,...
iTeos Logo 2022.png
iTeos Therapeutics gibt registrierte Direktplatzierung im Wert von 120 Mio. USD bekannt
May 11, 2024 09:28 ET | iTeos Therapeutics Inc.
-Angeführt von den bestehenden Investoren RA Capital Management und Boxer Capital- Kaufpreis von 17,50 USD entspricht einem Aufschlag von ca. 44 % auf den letzten Schlusskurs- Weitere Stärkung der...
Atlanticus_FullColor_tagline_2.jpg
Atlanticus Reports First Quarter 2024 Financial Results
May 10, 2024 22:00 ET | Atlanticus Holdings Corp
ATLANTA, May 10, 2024 (GLOBE NEWSWIRE) -- Atlanticus Holdings Corporation (NASDAQ: ATLC) (Atlanticus, the Company, we, our or us), a financial technology company which enables its bank, retail and...
Tevogen Logo Notified.png
Tevogen Bio Announces Up to $50 Million in Financing to Further Advance Operational Objectives
May 10, 2024 17:40 ET | Tevogen Bio Inc
$50 million in financing advances operational objectives and bolsters a financial path to positive cashflow with minimal dilution.
image1 (1).png
Evaxion Receives Nasdaq Notification
May 10, 2024 17:00 ET | Evaxion Biotech
COPENHAGEN, Denmark, May 10, 2024 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage TechBio company specializing in developing AI-Immunology™...
Victoria Gold Corp TSXVGCX logo.jpg
Victoria Gold: New Director & Annual General Meeting Results
May 10, 2024 17:00 ET | Victoria Gold Corp
VANCOUVER, British Columbia, May 10, 2024 (GLOBE NEWSWIRE) -- Victoria Gold Corp. (TSX-VGCX) (“Victoria” or the “Company”) held its Annual General Meeting (the "Meeting") earlier today, May 10,...
Atrion Logo.jpg
Atrion Reports First Quarter 2024 Results
May 10, 2024 16:10 ET | Atrion Corporation
ALLEN, Texas, May 10, 2024 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ: ATRI) today announced its results for the first quarter ended March 31, 2024. Revenues for the first quarter of 2024...
The Herzfeld Caribbean Basin Fund, Inc. Pays Quarterly Distribution
May 10, 2024 16:01 ET | Herzfeld Caribbean Basin Fund
MIAMI BEACH, Fla., May 10, 2024 (GLOBE NEWSWIRE) -- The Herzfeld Caribbean Basin Fund, Inc. (NASDAQ: CUBA) (the “Fund”) today announced that the Fund has made the following distribution pursuant to...
download.jpg
QuidelOrtho (QDEL) Securities Fraud Class Action Filed After QDEL Reports Disastrous Q4 2023 Results, Terminates CEO, Withdraws FDA Submission - Hagens Berman
May 10, 2024 13:29 ET | Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, May 10, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges QuidelOrtho Corporation (NASDAQ: QDEL) investors who suffered substantial losses to submit your losses now. Class Period: Feb....